| Unique ID issued by UMIN | UMIN000061857 |
|---|---|
| Receipt number | R000070779 |
| Scientific Title | Incremental diagnostic value of pericoronary adipose tissue attenuation for the detection of vulnerable plaques |
| Date of disclosure of the study information | 2026/06/10 |
| Last modified on | 2026/06/10 13:26:09 |
Incremental diagnostic value of pericoronary adipose tissue attenuation for the detection of vulnerable plaques
Pericoronary adipose tissue attenuation for identification of vulnerable plaques
Incremental diagnostic value of pericoronary adipose tissue attenuation for the detection of vulnerable plaques
Incremental diagnostic value of pericoronary adipose tissue attenuation for the detection of vulnerable plaques
| Japan |
Acute coronary syndrome
| Cardiology |
Others
NO
This study also aims to evaluate whether adding PCAT attenuation to morphological and physiological CT-derived indices improves the discrimination and reclassification of ACS culprit lesions with plaque rupture.
Others
This study aims to investigate whether pericoronary adipose tissue (PCAT) attenuation provides incremental diagnostic value beyond morphological and physiological CT-derived indices for detecting vulnerable plaques associated with the development of acute coronary syndrome.
Whether the target lesion was identified as the ACS culprit lesion associated with plaque rupture
Differences in PCAT attenuation between ACS culprit lesions with plaque rupture and non-culprit lesions
Observational
| 20 | years-old | <= |
| 90 | years-old | >= |
Male and Female
1. Patients who developed acute coronary syndrome (ACS) due to plaque rupture as defined by percutaneous coronary intervention performed at the participating institutions between January 1, 2016 and December 31, 2025.
2. Patients in whom plaque rupture at the culprit lesion was identified by intravascular imaging, including intravascular ultrasound and/or optical coherence tomography, at the time of ACS.
2. Among the above patients, those who underwent coronary CT between 1 month and 2 years before the onset of ACS.
1. Patients who developed ACS due to restenosis-related lesions.
2. Patients who underwent coronary artery bypass grafting.
3. Patients with inadequate image quality on coronary CT.
150
| 1st name | Takayoshi |
| Middle name | |
| Last name | Toba |
Kobe University Graduate School of Medicine
Division of Cardiovascular Medicine, Department of Internal Medicine
650-0017
7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japan
078-382-5846
taka02222003@gmail.com
| 1st name | Takayoshi |
| Middle name | |
| Last name | Toba |
Kobe University Graduate School of Medicine
Division of Cardiovascular Medicine, Department of Internal Medicine
650-0017
7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo
078-382-5846
taka02222003@gmail.com
Others
None.
Other
Kobe University Hospital Clinical & Translational Research Center
7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan
078-382-6669
kansatsu@med.kobe-u.ac.jp
NO
| 2026 | Year | 06 | Month | 10 | Day |
Unpublished
Preinitiation
| 2026 | Year | 06 | Month | 10 | Day |
| 2026 | Year | 08 | Month | 01 | Day |
| 2028 | Year | 03 | Month | 31 | Day |
This study is a single-center retrospective observational study conducted by Kobe University Hospital as the research institution, using existing information provided by institutions that will only provide such information. The use of existing information is scheduled to begin on August 1, 2026, and the planned sample size is 150 patients.
| 2026 | Year | 06 | Month | 10 | Day |
| 2026 | Year | 06 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070779